Smoking Cessation E-Visit
Development and Testing of a Smoking Cessation E-Visit for Implementation in Primary Care
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- current smoking, defined as smoking 5+ cigarettes/day, for 20+ days out of the last 30, for the last 6+ months
- age 18+
- enrolled in Epic's MyChart program or willing to sign up for MyChart
- possess a valid e-mail address that is checked daily to access follow-up assessments and MyChart messages
- English fluency
Exclusion Criteria:
None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Smoking cessation electronic visit (e-visit)
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking and 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit.
|
electronic visits (e-visits) for smoking cessation
|
|
Active Comparator: Treatment As Usual
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
|
Information about the state quitline and about the importance of quitting smoking and a recommendation to contact one's PCP to schedule a medical visit to discuss quitting smoking
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Utilized Smoking Cessation Treatment
Time Frame: Month 1
|
Number of participants who utilized smoking cessation treatment since last assessment.
|
Month 1
|
|
Number of Participants Who Utilized Smoking Cessation Treatment
Time Frame: Month 3
|
Number of participants who utilized smoking cessation treatment since last assessment.
|
Month 3
|
|
Cigarettes Smoking
Time Frame: Month 1
|
Cigarettes per day reduction greater than 50%
|
Month 1
|
|
Cigarettes Smoking
Time Frame: Month 3
|
Cigarettes per day reduction greater than 50%
|
Month 3
|
|
Quit Attempts
Time Frame: Month 1
|
Quit attempts since last contact
|
Month 1
|
|
Quit Attempts
Time Frame: Month 3
|
Quit attempts since last contact
|
Month 3
|
|
24-hour Quit Attempt
Time Frame: Month 1
|
Quit attempt lasting 24 hours since last contact
|
Month 1
|
|
24-hour Quit Attempt
Time Frame: Month 3
|
Quit attempt lasting 24 hours since last contact
|
Month 3
|
|
Seven-day Point Prevalence Abstinence
Time Frame: Month 1
|
Participant has not had a cigarette in the past 7 days
|
Month 1
|
|
Seven-day Point Prevalence Abstinence
Time Frame: Month 3
|
Participant has not had a cigarette in the past 7 days
|
Month 3
|
|
Floating Abstinence
Time Frame: Month 1
|
Participant has gone 7+ days without a cigarette since last contact.
|
Month 1
|
|
Floating Abstinence
Time Frame: Month 3
|
Participant has gone 7+ days without a cigarette since last contact.
|
Month 3
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
E-visit Completion
Time Frame: Month 1
|
Number of participants that completed the e-visit
|
Month 1
|
|
Provider Fidelity
Time Frame: Month 1
|
Reviewing within Epic whether the provider administered treatment consistent with e-visit recommendations
|
Month 1
|
|
E-visit Ease of Use
Time Frame: Month 1
|
Participants reported Agree or Strongly Agree to finding the e-visit easy to use question
|
Month 1
|
|
Time to Complete the E-visit
Time Frame: Month 1
|
Time (days) to complete the e-visit among participants that completed the e-visit.
|
Month 1
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Pro00078077
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.